{"_links": {"parentPackage": {"href": "/mdr/ct/packages/sendct-2020-03-27", "title": "SEND Controlled Terminology Package 41 Effective 2020-03-27", "type": "Terminology"}, "priorVersion": {"href": "/mdr/ct/packages/sendct-2019-12-20/codelists/C90003", "title": "CDISC SEND Study Type Terminology", "type": "Code List"}, "rootItem": {"href": "/mdr/root/ct/sendct/codelists/C90003", "title": "Version-agnostic anchor resource for codelist C90003", "type": "Root Value Domain"}, "self": {"href": "/mdr/ct/packages/sendct-2020-03-27/codelists/C90003", "title": "CDISC SEND Study Type Terminology", "type": "Code List"}}, "conceptId": "C90003", "definition": "Terminology relevant to the type of nonclinical study performed.", "extensible": "true", "name": "SEND Study Type", "preferredTerm": "CDISC SEND Study Type Terminology", "submissionValue": "SSTYP", "synonyms": ["SEND Study Type"], "terms": [{"conceptId": "C79369", "definition": "The branch of pharmacokinetics that studies the process by which a drug is absorbed by the body.", "preferredTerm": "Pharmacokinetics: Absorption", "submissionValue": "ABSORPTION", "synonyms": ["FDA RPS Pharmacokinetics: Absorption"]}, {"conceptId": "C15967", "definition": "A study that is designed to investigate the absorption, distribution, metabolism and excretion of a drug.", "preferredTerm": "ADME Study", "submissionValue": "ADME", "synonyms": ["Absorption, Distribution, Metabolism and Excretion"]}, {"conceptId": "C79368", "definition": "An indication or description of the process by which the truth of something is tested or found.", "preferredTerm": "Analytical Methods and Validation Reports", "submissionValue": "ANALYTICAL METHODS AND VALIDATION REPORTS", "synonyms": ["FDA RPS Analytical Methods And Validation Reports"]}, {"conceptId": "C79391", "definition": "A toxicity study that assesses the ability of a substance to induce an antigenic response in an animal.", "preferredTerm": "Other Toxicity Studies: Antigenicity", "submissionValue": "ANTIGENICITY", "synonyms": ["FDA RPS Other Toxicity Studies: Antigenicity"]}, {"conceptId": "C49664", "definition": "A study of the degree to which or rate at which a drug or other substance is absorbed or becomes available at the site of physiological activity after administration. (NCI)", "preferredTerm": "Bioavailability Study", "submissionValue": "BIOAVAILABILITY"}, {"conceptId": "C79380", "definition": "A study that assesses the toxic effects of a compound in animals after repeated administrations with particular emphasis on determining the carcinogenicity of the compound.", "preferredTerm": "Toxicology: Carcinogenicity", "submissionValue": "CARCINOGENICITY", "synonyms": ["FDA RPS Toxicology: Carcinogenicity"]}, {"conceptId": "C18079", "definition": "The study of the effects of drugs upon the heart or circulatory system.", "preferredTerm": "Cardiovascular Pharmacology", "submissionValue": "CARDIOVASCULAR PHARMACOLOGY"}, {"conceptId": "C90370", "definition": "The branch of pharmacology that deals with the central nervous system. (NCI)", "preferredTerm": "Central Nervous System Pharmacology", "submissionValue": "CNS PHARMACOLOGY"}, {"conceptId": "C79394", "definition": "A study that assesses the capacity of a substance to become an abuse liability.", "preferredTerm": "Other Toxicity Studies: Dependence", "submissionValue": "DEPENDENCE", "synonyms": ["FDA RPS Other Toxicity Studies: Dependence"]}, {"conceptId": "C79370", "definition": "The branch of pharmacokinetics that studies the process by which a drug is distributed by the body.", "preferredTerm": "Pharmacokinetics: Distribution", "submissionValue": "DISTRIBUTION", "synonyms": ["FDA RPS Pharmacokinetics: Distribution"]}, {"conceptId": "C158357", "definition": "A study that assesses the efficacy of prophylactic treatment given after exposure to the challenge agent(s) but before the manifestation of the disease or condition.", "preferredTerm": "Efficacy Study With Post-Exposure Prophylaxis", "submissionValue": "EFFICACY, POST-EXPOSURE PROPHYLAXIS"}, {"conceptId": "C158358", "definition": "A study that assesses the efficacy of a radiomitigator (given after exposure to the challenge agent(s) but before the manifestation of the disease or condition).", "preferredTerm": "Efficacy Study With Post-Exposure Radiomitigation", "submissionValue": "EFFICACY, POST-EXPOSURE RADIOMITIGATION"}, {"conceptId": "C158356", "definition": "A study that assesses the efficacy of prophylactic treatment (including radioprotectors) given before exposure to the challenge agent(s).", "preferredTerm": "Efficacy Study With Pre-Exposure Prophylaxis", "submissionValue": "EFFICACY, PRE-EXPOSURE PROPHYLAXIS"}, {"conceptId": "C158465", "definition": "A study that assesses the efficacy of treatment given after a protocol-defined manifestation of the challenge agent(s)-induced disease or condition.", "preferredTerm": "Challenge Agent Treatment Efficacy Study", "submissionValue": "EFFICACY, TREATMENT"}, {"conceptId": "C79386", "definition": "A toxicity study that assesses the effects of a substance on embryonic and fetal development.", "preferredTerm": "Reproductive and Developmental Toxicity: Embryofetal Development", "submissionValue": "EMBRYO FETAL DEVELOPMENT", "synonyms": ["FDA RPS Reproductive And Developmental Toxicity: Embryofetal Development"]}, {"conceptId": "C79372", "definition": "The branch of pharmacokinetics that studies the process by which a drug is eliminated by the body.", "preferredTerm": "Pharmacokinetics: Excretion", "submissionValue": "EXCRETION", "synonyms": ["FDA RPS Pharmacokinetics: Excretion"]}, {"conceptId": "C79385", "definition": "A study that assesses the effects of a substance on an organism's fertility and/or embryonic development.", "preferredTerm": "Reproductive and Developmental Toxicity: Fertility and Early Embryonic Development", "submissionValue": "FERTILITY AND EARLY EMBRYONIC DEVELOPMENT", "synonyms": ["FDA RPS Reproductive And Developmental Toxicity: Fertility And Early Embryonic Development"]}, {"conceptId": "C90388", "definition": "The branch of pharmacology that deals with the gastrointestinal system. (NCI)", "preferredTerm": "Gastrointestinal Pharmacology", "submissionValue": "GASTROINTESTINAL PHARMACOLOGY"}, {"conceptId": "C79378", "definition": "A genotoxicity study that tests the ability of a substance to cause DNA damage not in intact animals, but in cells or other systems.", "preferredTerm": "Genotoxicity: In Vitro", "submissionValue": "GENOTOXICITY IN VITRO", "synonyms": ["FDA RPS Genotoxicity: In Vitro"]}, {"conceptId": "C79379", "definition": "A genotoxicity study that tests the ability of a substance to cause DNA damage within the body.", "preferredTerm": "Genotoxicity: In Vivo", "submissionValue": "GENOTOXICITY IN VIVO", "synonyms": ["FDA RPS Genotoxicity: In Vivo"]}, {"conceptId": "C79392", "definition": "A toxicity study that assesses potential harm to the immune system.", "preferredTerm": "Other Toxicity Studies: Immunotoxicity", "submissionValue": "IMMUNOTOXICITY", "synonyms": ["FDA RPS Other Toxicity Studies: Immunotoxicity"]}, {"conceptId": "C79396", "definition": "A study that assesses the effects of impurities that may be found in a substance.", "preferredTerm": "Other Toxicity Studies: Impurities", "submissionValue": "IMPURITIES", "synonyms": ["FDA RPS Other Toxicity Studies: Impurities"]}, {"conceptId": "C79388", "definition": "A toxicology study that assesses the effects of a substance on a subject that received treatment and/or was dosed beginning during the juvenile stage of development.", "preferredTerm": "Studies in which the Offspring (Juvenile Animals) are Dosed and/or Further Evaluated", "submissionValue": "JUVENILE STUDIES", "synonyms": ["FDA RPS Studies In Which The Offspring (Juvenile Animals) Are Dosed And/Or Further Evaluated"]}, {"conceptId": "C79389", "definition": "A toxicology study that assesses the effects of a substance when administered to a restricted portion of the body.", "preferredTerm": "Toxicology: Local Tolerance", "submissionValue": "LOCAL TOLERANCE", "synonyms": ["FDA RPS Toxicology: Local Tolerance"]}, {"conceptId": "C79393", "definition": "A study that investigates the process by which a substance induces its effects.", "preferredTerm": "Other Toxicity Studies: Mechanistic Studies", "submissionValue": "MECHANISTIC STUDIES", "synonyms": ["FDA RPS Other Toxicity Studies: Mechanistic Studies"]}, {"conceptId": "C79371", "definition": "The branch of pharmacokinetics that studies the process by which a drug is metabolized by the body.", "preferredTerm": "Pharmacokinetics: Metabolism", "submissionValue": "METABOLISM", "synonyms": ["FDA RPS Pharmacokinetics: Metabolism"]}, {"conceptId": "C79395", "definition": "A study that evaluates the effects of a metabolite of a substance.", "preferredTerm": "Other Toxicity Studies: Metabolites", "submissionValue": "METABOLITES", "synonyms": ["FDA RPS Other Toxicity Studies: Metabolites"]}, {"conceptId": "C16147", "definition": "A study that monitors the development and progression of a disease or condition.", "preferredTerm": "Natural History", "submissionValue": "NATURAL HISTORY"}, {"conceptId": "C112431", "definition": "A study to test whether certain biological agents (e.g., viruses) or materials (e.g., nucleic acids) are capable of immortalizing cells and endowing them with the capacity to form tumors.", "preferredTerm": "Oncogenicity", "submissionValue": "ONCOGENICITY"}, {"conceptId": "C79367", "definition": "The branch of pharmacology that deals with the mechanism of action and biochemical and physiological effects of drug-drug interactions.", "preferredTerm": "Pharmacology: Pharmacodynamic Drug Interactions", "submissionValue": "PHARMACODYNAMIC DRUG INTERACTIONS", "synonyms": ["FDA RPS Pharmacology: Pharmacodynamic Drug Interactions"]}, {"conceptId": "C79373", "definition": "The branch of pharmacokinetics that studies the process by which two or more drugs in a system are absorbed, distributed, metabolized, and eliminated by the body.", "preferredTerm": "Pharmacokinetics: Drug Interactions", "submissionValue": "PHARMACOKINETIC DRUG INTERACTIONS", "synonyms": ["FDA RPS Pharmacokinetics: Drug Interactions"]}, {"conceptId": "C116216", "definition": "A study that assesses a toxic response from a substance which is either elicited or increased (apparent at lower dose levels) after subsequent exposure to light, or that is induced by skin irradiation after systemic administration of a substance (adapted from OECD Guideline for Testing of Chemicals, copyright OECD, 2004, TG 432).", "preferredTerm": "Phototoxicity Study", "submissionValue": "PHOTOTOXICITY"}, {"conceptId": "C79387", "definition": "A toxicity study that assesses the effects of a substance on an organism's development shortly before and after birth.", "preferredTerm": "Reproductive and Developmental Toxicity: Prenatal and Postnatal Development Including Maternal Function", "submissionValue": "PRENATAL AND POSTNATAL DEVELOPMENT", "synonyms": ["FDA RPS Reproductive And Developmental Toxicity: Prenatal And Postnatal Development Including Maternal Function"]}, {"conceptId": "C79364", "definition": "The branch of pharmacology that deals with the biochemical and physiological effects of a drug and the mechanism of drug action in relation to its desired therapeutic target.", "preferredTerm": "Pharmacology: Primary Pharmacodynamics", "submissionValue": "PRIMARY PHARMACODYNAMICS", "synonyms": ["FDA RPS Pharmacology: Primary Pharmacodynamics"]}, {"conceptId": "C18996", "definition": "The science concerned with drugs and their actions and uses in kidney biology and the treatment of kidney disease. (NCI)", "preferredTerm": "Renal Pharmacology", "submissionValue": "RENAL PHARMACOLOGY"}, {"conceptId": "C79376", "definition": "A study that assesses the toxic effects of a compound in animals after repeated administrations.", "preferredTerm": "Toxicology: Repeat Dose Toxicity [Species, Route, Duration]", "submissionValue": "REPEAT DOSE TOXICITY", "synonyms": ["FDA RPS Toxicology: Repeat Dose Toxicity"]}, {"conceptId": "C90449", "definition": "The branch of pharmacology that deals with the respiratory system. (NCI)", "preferredTerm": "Respiratory Pharmacology", "submissionValue": "RESPIRATORY PHARMACOLOGY"}, {"conceptId": "C79365", "definition": "The branch of pharmacology that deals with the biochemical and physiological effects of a drug and the mechanism of drug action not related to its desired therapeutic target.", "preferredTerm": "Pharmacology: Secondary Pharmacodynamics", "submissionValue": "SECONDARY PHARMACODYNAMICS", "synonyms": ["FDA RPS Pharmacology: Secondary Pharmacodynamics"]}, {"conceptId": "C79375", "definition": "A study that assesses the toxic effects of a compound in animals after a single administration.", "preferredTerm": "Toxicology: Single Dose Toxicity [Species and Route]", "submissionValue": "SINGLE DOSE TOXICITY", "synonyms": ["FDA RPS Toxicology: Single Dose Toxicity"]}, {"conceptId": "C90478", "definition": "Evaluation of the absorption, distribution, metabolism and excretion of a substance in relation to its toxicity in an animal.", "preferredTerm": "Toxicokinetics", "submissionValue": "TOXICOKINETICS"}, {"conceptId": "C19501", "definition": "A study in which immortalized cells form tumors when inoculated into animals.", "preferredTerm": "Tumorigenicity", "submissionValue": "TUMORIGENICITY"}]}